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A new replicon suitable for cloning and gene expression was successfully introduced into 
Streptococcus pneumoniae. The non-integrative lactococcal vectors pIL253 (high-copy) and 
pIL252 (low-copy), which are based on the promiscuous theta-replicating plasmid pAMβ1, 
were established in pneumococcus. The stability and the small size of these plasmids, 
together with the presence of a helpful multi-cloning site make them a useful genetic tool for 
gene expression in this bacterium. The functionality of the system was tested by cloning and 
expressing the pneumococcal RNase R in pIL253. Full constitutive expression of the cloned 
gene was observed, clearly demonstrating that this plasmid can be used as an expression 
vector in S. pneumoniae. Moreover, gene expression can be regulated by the use of the low- 
or high-copy vector versions. The existence of other replicative plasmids based on this family, 
which are also probably functional in pneumococcus, further broadens the cloning 
possibilities. We also show that S. pneumoniae cells can accommodate simultaneously 
pIL252 or pIL253 together with pLS1plasmid, a pMV158 derivative, which replicates via rolling 
circle mechanism. This fact greatly increases the ability to manipulate this bacterium. 
The availability of a new family of replicative vectors for genetic manipulation in S. 
pneumoniae is an important contribution to the study of this pathogenic microorganism. 
1. Introduction 
The pathogenic Gram-positive bacterium S. pneumoniae is one of the leading causes of 
nosocomial infections. Although normally found as a harmless commensal of the human 
upper respiratory tract, it may cause invasive infections like pneumonia, meningitis or sepsis, 
when the immune system weakens. Normal disease development begins with colonization of 
the nasopharynx followed by progression to the lung or bloodstream. Collectively, these 
diseases result in millions of deaths worldwide each year, affecting especially young children 
and the elderly. Understanding the mechanisms of pathogenesis is essential to identify new 
potential targets that can be used to design innovative drugs effective to combat this 
microorganism. This has prompted increased efforts to study this bacterium at the molecular 
level, which often requires the use of refined genetic tools. Although S. pneumoniae is a 
naturally transformable bacterium only a few indigenous cryptic plasmids have been identified 
and most of the plasmid vectors used for its manipulation were isolated from heterologous 
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hosts. A shuttle vector between S. pneumoniae and Escherichia coli based on an indigenous 
plasmid has also been constructed {Munoz, 1999 #12}. However, non-integrative plasmid 
vectors are still very scarce and most of the studies have been carried out on the broad host 
range, rolling circle replicating (RCR) plasmid pMV158 {Burdett, 1980 #13} and on its 
derivative, pLS1 {Stassi, 1981 #14}. A set of plasmids based on this promiscuous replicon 
that can be used as gfp-fusions vectors using Green Fluorescent Protein (GFP) as a reporter 
for gene expression have been constructed {Acebo, 2000 #17;Fernandez de Palencia, 2000 
#15;Nieto, 2000 #16;Nieto, 2003 #18}. An improved vector for regulated gene expression 
based on the same system has recently been reported {Ruiz-Maso, 2012 #19}. pLS1 
derivatives allowing expression of mCherry or citrine fusion proteins have also been designed 
{Henriques, 2011 #20} and a plasmid tool based on pLS1 is available to study promoter and 
terminator sequences in S. pneumoniae and Enterococcus faecalis {Ruiz-Cruz, 2010 #21}. 
However, most of the pLS1 derivatives are large plasmids that are not easy to handle. Most of 
them lack a useful multi-cloning site and the respective sequence is often not available.  
These observations prompted us to search for cloning vectors based in another replicon that 
could be suitable for the expression of genes in S. pneumoniae. pIL253 is a pAMβ1-based 
plasmid, a well characterized theta-replicating promiscuous replicon isolated from 
Enterococcus faecalis {Bruand, 1991 #22}. Plasmids belonging to the pIL253 family were 
initially constructed for molecular cloning in Lactococcus lactis and have been extensively 
used for gene cloning and expression in Gram-positive bacteria. This is mainly due to their 
small size (< 5 kb) and stability, the presence of a useful multi-cloning site (MCS), sequence 
availability and their demonstrated ability to stably maintain large DNA inserts in L. lactis 
{Simon, 1988 #7}. Furthermore they are available in low- (pIL252) or high- (pIL253) copy 
number versions {Simon, 1988 #7}, which allows a better control of gene expression. 
In this work we have examined the capability of these plasmids to be used as vectors for 
cloning and gene expression in S. pneumoniae. We show that pIL253 autonomously 
replicates and is stably maintained in this bacterium. Cloning of RNase R into pIL253 yielded 
high levels of RNA and protein, readily demonstrating the utility of this plasmid family as a 
pneumococcal expression vector. In addition the compatibility of pIL252 or pIL253 with pLS1, 
demonstrated in this work, is undoubtedly one the most useful properties of these plasmids. 
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2. Material and methods 
2.1. Bacterial strains and growth conditions 
All strains used in this work are listed in Table 1. S. pneumoniae TIGR4 {Tettelin, 2001 #1} 
and derivatives were routinely grown in Todd Hewitt medium, supplemented with 0.5 % yeast 
extract (THY), at 37°C without shaking or in Trypticasein soy broth (TSB) agar plates 
supplemented with 5% sheep blood. When required the growth medium was supplemented 
with 2.5 or 3 µg/ml chloramphenicol (Cm), 5 μg/ml erythromycin (Ery) or 1 µg/ml tetracycline 
(Tet) as specified bellow. E. coli was cultivated in Lysogeny broth (LB) at 37 ºC with agitation. 
The growth medium was supplemented with 100 μg/ml ampicillin (Amp) when required. 
All oligonucleotides used in this work were synthesized by STAB Vida, Portugal. 
2.2. DNA manipulations and plasmids  
The lactococcal plasmid vectors pIL252 and pIL253 {Simon, 1988 #7} were transformed into 
S. pneumoniae TIGR4. Pneumococcal transformation was performed essentially as described 
{Burghout, 2007 #2}. Briefly pre-competent pneumococcal cells were grown for 10 min at 
37°C in a 10-fold volume of CTM-pH 7.8 {Burghout, 2007 #2} supplemented with 125 ng/ml 
CSP-2 (the synthetic competence-stimulating peptide 2). Media were supplemented with Tet, 
when cells previously carried pLS1. 200 ng of plasmid DNA were then added and cultures 
were further incubated at 30 ºC for 30 min and then shifted to 37 ºC. One hour and thirty 
minutes after the temperature shift, transformants were selected on solid medium 
supplemented with 1 µg/ml Ery. 
Isolation of plasmid DNA from S. pneumoniae was performed using the Wizard Plus SV 
Minipreps DNA purification system (Promega) with some modifications. Exponentially growing 
cells were harvested and resuspended in TES (25 mM Tris pH 8, 10 mM EDTA, 1.7 % 
saccharose) supplemented with 8 mg/ml lysozyme and incubated at 37 ºC for 15 min. The 
suspension was centrifuged at 2350 x g for 5 min, and the cell pellet was resuspended in 0.9 
M NaCl (200 µl) and centrifuged again under the same conditions. The pellet was then 
processed following the supplier's instructions. Plasmid DNA was digested with PstI 
(Fermentas), as recommended by the supplier. 
pIL253 carrying the coding sequence of the TIGR4 RNase R inserted into the SmaI/PstI sites 
of the plasmid MCS {Moreira, in press #29} was used to assess the ability of pIL253 to stably 
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carry and express a DNA fragment in S. pneumoniae. Expression of RNase R was evaluated 
by transforming this construction into a S. pneumoniae TIGR4 RNase R- mutant strain (see 
below). Transformants were selected with 1 µg/ml Ery and were further propagated in media 
containing Cm (3 µg/ml) and Ery (1 μg/ml). 
The S. pneumoniae RNase R deficient mutant was created through allelic replacement 
mutagenesis, using a DNA fragment containing the rnr flanking regions, in which rnr is 
replaced by a chloramphenicol resistance cassette (cat). The cat marker was amplified with 
primers smd013 (GATAAGCTTGATGAAAATTTG) and smd014 
(CATTATCTCATATTATAAAAG). The upstream and downstream rnr flanking regions were 
amplified by PCR using the primer pairs smd011 (5’-
CCGGAATTCGGACTCTATCGTTTCCTCTTTG-3’) / smd015 (5’-
CAAATTTTCATCAAGCTTATCATTTTCTTTCTAGATTTTTTAATTTTC-3’) and smd016 (5’-
CTTTTATAATATGAGATAATGAAGGAAGTAGCTAAGAAAGGAG-3’) / smd012 (5’-
CGCGGATCCAATGAACAGGATTGGTATTG-3’), respectively. Primers smd015 and smd016 
included 3’ extensions complementary to the 5’- and 3’-end respectively of the cat marker. 
The PCR amplified fragments with the complementary extensions were used as templates 
together with the cat marker to obtain a final PCR product. This product, which contained the 
rnr flanking regions surrounding the cat cassette, was inserted into the sites EcoRI/BamHI of 
pUC19 (Invitrogen) and propagated in E. coli DH5α. The recombinant plasmid was purified as 
described by Birnboim and Doly {Birnboim, 1979 #27}, linearized with EcoRI and used to 
transform S. pneumoniae 708 strain {Lacks, 1970 #28}. Competence and transformation 
procedures were performed according to {Lacks, 1968 #26}. Transformants were selected 
with Cm (2.5 g/ml), and the correct nucleotide sequence of the rnr::cat chromosomal insert 
was confirmed by DNA sequencing. Then, chromosomal DNA from S. pneumoniae 708 
(rnr::cat) mutant (1 µg/ml) and the synthetic CSP-2 (25 ng/ml) were used to transform the S. 
pneumoniae TIGR4 strain as above. Transformants containing the rnr::cat in their 
chromosome were selected for Cm (2.5 g/ml) and the correct nucleotide sequence was 
confirmed by DNA sequencing.  
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2.3. Plasmid segregational stability 
Segregational stability was tested according to Simon and Chopin {Simon, 1988 #7}. Briefly, 
an overnight culture of S. pneumoniae TIGR4 containing pIL253 grown in medium 
supplemented with Ery was diluted to an OD600 of 0.05 in fresh THY without antibiotic. The 
culture was allowed to grow until early stationary phase and then plated onto non-selective 
TSB agar. The fraction of erythromycin-resistant clones was determined by transferring ~150 
of those colonies onto erythromycin-free and erythromycin-containing TSB agar plates. 
 
2.4. Determination of copy number 
Pneumococcal cultures of TIGR4 carrying pLS1, pIL252 or pIL253, were grown to an OD650 = 
0.45. Total DNA was prepared and fractionated in 1% agarose as described by Acebo et al. 
{Acebo, 1996 #30}. Gels were stained with ethidium bromide (0.5 µg mL-1) for 1 h and the 
intensity of the DNA bands was quantified by use of a Gel Doc 2000 instrument and the 
Quantity One 4.6.5 software (BioRad laboratories)  
The average number of plasmid copy number (from four determinations) was calculated by 
the use of the following equation developed by Projan et al. {Projan, 1983 #31}:  
 
Where Dp1 and Dp2 are, respectively, the intensity values determined for the open and 
covalently closed plasmid forms. Mc is the molecular weight of the S. pneumoniae TIGR4 
chromosome (2160837 bp) and Dc is the intensity value for the chromosomal DNA. is the 
molecular weight of the plasmids: pLS1 (4408 bp), pIL252 (4698 bp) and pIL253 (4963 nt). 
The coefficient 1.36 is introduced to correct the differences in fluorescence due to the 
efficiency of ethidium bromide for intercalation in open circle and supercoiled DNA. 
2.5. RNA Extraction 
Overnight cultures of S. pneumoniae TIGR4 wild type and derivatives were diluted in pre-
warmed THY to a final OD600 of 0.1, and incubated at 37 ºC until OD600 ~ 0.3. At this point, 
cultures were split into two aliquots and each was further incubated at 15 ºC or 37 ºC for 2 h. 
20 ml culture samples were collected, mixed with 1 volume of stop solution (10 mM Tris pH 
7.2, 25 mM NaNO3, 5 mM MgCl2, 500 µg/ml chloramphenicol) and harvested by 
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centrifugation (10 min, 2800 x g, 4 ºC). Total RNA was extracted using Trizol reagent 
(Ambion) essentially as described by the manufacturer, with some modifications. 
Pneumococcal cells were lysed by incubation in 650 µl lysis buffer (sodium citrate 150 mM, 
saccharose 25 %, sodium deoxicholate 0.1 %, SDS 0.01 %) for 15 min at 37 ºC followed by 
addition of 0.1 % SDS. After lysis, samples were treated with 10 U Turbo DNase (Ambion) for 
1 h at 37 ºC. After extraction, the RNA integrity was evaluated by gel electrophoresis and its 
concentration estimated using a Nanodrop 1000 machine (Nanodrop Technologies).  
2.6. Reverse Transcription-PCR (RT-PCR) 
RT-PCR reactions were carried out using total RNA, with the OneStep RT-PCR kit (Qiagen), 
according to the supplier’s instructions. The primer pair seqT4-2 
(GACATCGCTATAGGTCATACG) / seqT4-3(GTTTGACAACAGTTGTCGGG) was used to 
analyze rnr expression. As an independent control, 16S rRNA was amplified with specific 
primers 16sF (AGAGTTTGATCCTGGCTCAG) and 16sR (ACGGCTACCTTGTTACGACTT). 
Prior to RT-PCR, all RNA samples were treated with Turbo DNA free Kit (Ambion). Control 
experiments, run in the absence of reverse transcriptase, yielded no product. 
2.7. Total Protein Extraction and Western Blotting 
Cell cultures used to prepare protein extracts were grown in the same conditions as described 
above for RNA extraction. 20 ml culture samples were collected, mixed with 1 volume of stop 
solution (defined above) and harvested by centrifugation (10 min, 2800 xg, 4 ºC). The cell 
pellet was resuspended in 100 µl of TE buffer supplemented with 1 mM PMSF, 0.15 % 
sodium deoxycholate and 0.01 % SDS. After 15 min incubation at 37 ºC, SDS was added to a 
final concentration of 1 %. Protein concentration was determined using a Nanodrop 1000 
machine (NanoDrop Technologies). 20 µg of total protein were separated in a 7 % tricine-
SDS-polyacrylamide gel, following the modifications described by {Haider, 2010 #3}. After 
electrophoresis, proteins were transferred to a nitrocellulose membrane (Hybond ECL, GE 
Healthcare) by electroblotting using the Trans-Blot SD semidry electrophoretic system (Bio-
Rad). The membrane was then probed with 1:500 dilution of anti-RNase R antibodies 
{Moreira, in press #29}. ECL anti-rabbit IgG peroxidase conjugated (Sigma) was used as the 
secondary antibody in a 1:10000 dilution. Immunodetection was conducted via a 
chemiluminescence reaction using Western Lightning Plus-ECL Reagents (PerkinElmer). 
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3. Results and discussion 
3.1. pIL253 autonomously replicates in S. pneumoniae 
The scarcity of non-integrative plasmid-vectors available to genetically manipulate S. 
pneumoniae (and which are mainly based on the replicon pMV158), associated with 
difficulties in handling the existent tools, prompted us to examine the ability of the lactococcal 
plasmid-vector pIL253 to autonomously replicate in S. pneumoniae. 
For this purpose, pIL253 was transformed into S. pneumoniae TIGR4 and Ery resistant 
clones were analyzed for the presence of the plasmid. As shown in Fig. 1 pIL253 was isolated 
from exponentially growing transformants propagated in selective medium, indicating that this 
plasmid is able to autonomously replicate in pneumococcus. However, although pIL253 is 
stable in S. pneumoniae in the presence of selective pressure, only 5 % of the cells still 
carried the plasmid after continuous growth in the absence of Ery. The plasmid extracted from 
these cells showed the same electrophoretic mobility forms as observed in the original L. 
lactis preparation. One fragment corresponding to the size of pIL253 (~5 kb) was observed 
after linearization of both plasmid preparations with the single cutter PstI (Fig. 1, lanes 3-4). 
Thus the plasmid isolated from S. pneumonia seems to be identical to the original L. lactis 
plasmid. The overall results indicate that pIL253 is structurally stable in S. pneumoniae and it 
can be stably maintained under selective pressure 
Since the use of low-copy number vectors is often an advantage, we also tested pIL252, 
which is a low-copy number version of pIL253. The rep promoter activity is repressed by the 
product of the repF gene, which is present in pIL252 but is disrupted in pIL253, leading to the 
respective low and high copy numbers of these vectors {Simon, 1988 #7}. Analogously to 
pIL253, pIL252 can only be stably maintained in S. pneumoniae under selective pressure: in 
the absence of the antibiotic only 5 % of the cells retain the plasmid.  
Together, the results presented here show that this vector family can be propagated in 
pneumococcal cells under antibiotic selective pressure. 
3.2. pIL252/pIL253 compatibility with pLS1 
An important property of a cloning vector is its compatibility with other vectors. Because they 
use different replication mechanisms, RCR- and theta-replicating vectors are often 
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compatible. Thus we tested if pIL253 could be maintained in S. pneumoniae together with 
pLS1. 
To this purpose S. pneumoniae TIGR4 cells carrying pLS1 were transformed with pIL252 or 
pIL253 and transformants, selected in media containing Tet and Ery, were tested for the 
presence of both plasmids. Plasmids extracted from exponentially growing single 
transformants were then compared with those extracted from double transformants by 
restriction analysis. The enzyme chosen (PstI) is a single cutter for pIL252/pIL253 and a 
double cutter for pLS1, giving rise to different sized fragments that can be easily identified. 
The result obtained with pIL252 is shown in Fig. 2. An analogous result was obtained when 
pIL253 was used instead (data not shown). The restriction analysis of plasmid DNA indicates 
that none of the plasmids underwent structural rearrangements. Thereby this result shows 
that pneumococcal cells are able to stably maintain both pIL252/pIL253 vectors and pLS1. 
This feature represents a major advantage for their genetic manipulation. 
3.3 Determination of pIL252 and pIL253 copy number 
Analysis of total DNA preparations (Fig. 3) revealed that pIL253 as well as pLS1 are mainly 
present in monomeric supercoiled forms, whereas in some instances pIL252 multimers where 
observed in S. pneumoniae TIGR4.  
Determination of plasmid copy number revealed the expected value of 20 + 2 for pLS1 as 
previously described {Lacks, 1986 #32;Acebo, 1996 #30}. The pIL252 plasmid presented a 
copy number of 27 + 2, whereas pIL253 showed 59 + 5. In addition, supporting the 
compatibility of pLS1 and the pIL plasmids, no significant influence in the copy number was 
observed by carrying pLS1/pIL252 or pLS1/pIL253 plasmids. However, unexpectively, it 
seems that in the presence of pLS1, pIL252 decreases the degree of multimerization. 
3.4. Gene cloning and expression from pIL253 
To assess the functionality of this plasmid as an expression vector in pneumococcus, the 
coding sequence of S. pneumoniae TIGR4 RNase R was inserted into the pIL253 multi-
cloning site and this construction was transferred into an RNase R deficient strain. RNase R 
expression from pIL253 was then evaluated by RT-PCR and Western blotting. Since RNase 
R is known to be a protein that exhibits the highest expression levels under cold shock 
{Cairrão, 2003 #4;Moreira, in press #29}, the experiments were conducted at 15 ºC and 37 
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ºC, to have a better comparison with RNase R expression from the chromosome. The results 
in Fig. 4 show that RNase R is highly expressed from pIL253. Both mRNA and protein levels 
are higher than those detected with the wild type strain even at 15 ºC. We also observe that 
expression from this plasmid seems to be constitutive and does not change with temperature. 
This plasmid has been extensively used for expression of homologous and heterologous 
genes in lactic acid bacteria and high expression levels have previously been reported (see 
for instance {de Vos, 1990 #8;van Alen-Boerrigter, 1991 #6;Kleerebezem, 1997 
#9;Domingues, 2004 #10}. The high expression level may be a consequence of the gene 
dosage effect, since the copy number of pIL253 was calculated to be about 57 copies / 
chromosome. Moreover, this vector is known to contain a promoter in the replication region 
that reads through into the multiple cloning site {de Vos, 1990 #8} and it is probably implicated 
in the expression of genes cloned in the same transcriptional orientation. Full detection of 
RNase R in late exponential cultures indicates that the DNA insert remains stable after 
several generations. In L. lactis this vector is able to stably support large DNA fragments (up 
to 30 kb) {Simon, 1988 #7}. Theta-replicating plasmids are in general structurally more stable 
than RCR plasmids and, for this reason they can accommodate and maintain large inserts 
{Kiewiet, 1993 #5}. Taken together these results clearly demonstrate that the lactococcal 
vector pIL253 is suitable for gene cloning and expression in S. pneumoniae. 
4. Conclusions 
A replicon derived from the stable theta-replicating plasmid pAMβ1, was introduced for the 
first time in S. pneumoniae. The pIL253 vector, a pAMβ1 derivative, was successfully used for 
the cloning and expression of a pneumococcal chromosomal gene in host cells of this 
species. Moreover, this small sized vector contains a functional multi-cloning site with several 
unique restriction sites and it is able to stably maintain large DNA inserts. The possibility of 
using the low-copy number version (pIL252) offers another option for the genetic manipulation 
of pneumococcus. Moreover, the availability of other plasmid refined tools constructed on the 
basis of this family with different cloning possibilities constitutes an extra advantage. Besides 
pIL253 and pIL252, pIL871, a chloramphenicol resistance derivative of pIL253 was also 
constructed {Domingues, 2004 #10}. pIL253 and pIL871 share the same replication protein 
and can be stably maintained in a mixture by double selection with erythromycin and 
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chloramphenicol in L. lactis {Domingues, 2004 #10}. This, which would allow the 
simultaneous expression of genes cloned independently in each of the vectors, is also an 
open possibility that can be tested in S. pneumoniae. We have also shown that pIL252/pIL253 
can be maintained in S. pneumonia simultaneously with pLS1. This result indicates that these 
replicons are compatible, which significantly broadens the applications of these cloning 
vectors. 
An interesting collection of plasmids (pTRK family) offers low- and high-copy number shuttle 
vectors carrying the E. coli p15A origin of replication incorporated respectively into pIL252 
and pIL253 {O'Sullivan, 1993 #23}. Some of these vectors enable blue/white screening of 
clones in lacZα-complementing E. coli strains. Moreover these vectors have been 
successfully introduced into Lactococcus, Enterococcus, Lactobacillus and Streptococcus 
{O'Sullivan, 1993 #23}, which reinforces the possibility to extend their use for the genetic 
manipulation of S. pneumoniae. The pIA plasmid family also supplies a collection of shuttle 
vectors that include pIL253-based plasmids. Extended multi-cloning sites were added 
together with different selective markers and the possibility of X-gal selection of recombinant 
colonies {Perez-Arellano, 2001 #24}. This is also a broad host-range plasmid family that has 
been introduced in several Gram-positive bacteria and may thus also be suitable for gene 
cloning into S. pneumoniae. 
We believe that this work, by introducing the use of novel plasmid-based refined genetic tools, 
opens new perspectives for the study and genetic manipulation of the important human 
pathogen S. pneumoniae.  
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Fig. 1 - Structural stability of pIL253. Plasmid DNA was extracted from over-night cultures of 
S. pneumonia TIGR4 carrying pIL253, grown in the presence of the selective pressure. 
Pneumococcal plasmid preparations were compared with the original L. lactis plasmid 
preparation before and after digestion with PstI. M- Molecular weight marker; 1- Original 
pIL253 preparation; 2- pIL253 extracted from S. pneumoniae; 3- Original pIL253 prep 
digested with PstI; 4- S. pneumoniae pIL253 prep digested with Pst1. 
 
Fig. 2 – Compatibility of pIL252 with pLS1. Plasmid DNA was extracted from exponentially 
growing cultures of S. pneumonia TIGR4 carrying pLS1, or pIL252, or both plasmids, in the 
presence of the respective antibiotics. Digestion of plasmid preparations with PstI is shown. 
M- Molecular weight marker; 1- pIL252; 2- pLS1; 3- pIL252 + pLS1. 
 
Fig. 3 - Analysis of pIL252 and pIL253 plasmids. Total DNA extracts from TIGR4 strain 





Fig. 4 - Expression of pneumococcal RNase R from pIL253. Western blot and RT-PCR 
analysis of protein and RNA samples extracted at different temperatures (15 ºC and 37 ºC) 
from S. pneumoniae TIGR4 wild type and derivatives as indicated on top of each lane. Details 
of experimental procedures are described in ‘Material and Methods’. (Upper panel) Analysis 
of rnr mRNA levels by RT-PCR. RT–PCR experiments were carried out with primers specific 
for rnr using 100 ng of total RNA extracted from the wild type (WT) and derivatives at 15 ºC or 
37 ºC, as indicated at the top of the lanes. The RNase R- mutant derivative was used as a 
negative control. RT-PCR with primers specific for 16S rRNA shows that there were no 
significant variations in the amount of RNA used in each sample. (Lower panel) Analysis of 
RNase R (∼92 kDa) expression by Western immunoblotting. 20 µg of each protein sample 
were separated in a 7 % tricine-SDS-polyacrylamide gel and blotted to a nitrocellulose 
membrane. RNase R was detected using specific antibodies. An RNase R- mutant strain was 
used as a negative control. A non-specific band (Control) detected with the same antibodies 
was used as loading control.  
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Table 1 – List of strains used in this work. 
 
  
Strain Relevant markers/Genotype Source/Reference 
E. coli    
DH5α F' fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 
recA1 relA1 endA1 thi-1 hsdR17a 
{Taylor, 1993 #25} 
S. pneumoniae    
708  {Lacks, 1968 #26} 
JNR7/87 (TIGR4)  {Tettelin, 2001 #1} 
CMA607 TIGR4 carrying pIL253 (Ery
R
) This work 
CMA608 TIGR4 carrying pIL252 (Ery
R
) This work 
CMA609 TIGR4 carrying pIL253 and pLS1 This work 










) carrying pIL253 (Ery
R
) expressing RNase R  {Moreira, in press #29} 
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